Table 1.
Men and women |
Women |
Men |
||||
---|---|---|---|---|---|---|
Sample size | Prevalence (95% CI) | Sample size | Prevalence (95% CI) | Sample size | Prevalence (95% CI) | |
Overall | 16,385 | 16.9 (16.11–17.69) | 9,820 | 17.1 (16.16–18.19) | 6,565 | 16.5 (15.41–17.71) |
Hispanic background | ||||||
Dominican | 1,470 | 18.1 (16.21–20.13) | 961 | 18.2 (15.60–21.08) | 509 | 18.0 (14.83–21.71) |
Central American | 1,730 | 17.7 (15.36–20.22) | 1,047 | 18.5 (15.59–21.82) | 683 | 16.9 (13.75–20.57) |
Cuban | 2,347 | 13.4 (12.03–14.91) | 1,249 | 13.5 (11.64–15.55) | 1,098 | 13.2 (11.45–15.14) |
Mexican | 6,466 | 18.3 (16.84–19.86) | 4,018 | 17.9 (16.18–19.74) | 2,448 | 18.7 (16.32–21.33) |
Puerto Rican | 2,719 | 18.1 (16.30–19.98) | 1,586 | 19.5 (16.98–22.23) | 1,133 | 16.6 (14.31–19.27) |
South American | 1,070 | 10.2 (8.36–12.29) | 634 | 9.8 (7.73–12.36) | 436 | 10.6 (7.85–14.09) |
Mixed/other | 502 | 21.2 (15.74–27.88) | 276 | 22.1 (14.92–31.49) | 226 | 19.6 (13.64–27.29) |
Missing | 81 | 57.4 (46.58–67.57) | 49 | 64.3 (51.10–75.62) | 32 | 43.1 (30.36–56.92) |
Age group, years | ||||||
18–29 | 2,675 | 2.6 (1.93–3.36) | 1,427 | 2.9 (1.98–4.11) | 1,248 | 2.2 (1.49–3.38) |
30–39 | 2,389 | 6.7 (5.49–8.15) | 1,384 | 6.4 (4.94–8.31) | 1,005 | 7.0 (5.23–9.28) |
40–49 | 4,204 | 14.1 (12.64–15.69) | 2,573 | 14.5 (12.68–16.59) | 1,631 | 13.6 (11.50–16.07) |
50–59 | 4,330 | 25.0 (23.06–27.09) | 2,727 | 26.2 (23.47–29.08) | 1,603 | 23.6 (21.03–26.32) |
60–69 | 2,287 | 38.7 (35.64–41.79) | 1,396 | 37.3 (33.44–41.28) | 891 | 40.3 (36.00–44.73) |
70–74 | 500 | 48.6 (41.57–55.64) | 313 | 51.3 (42.17–60.36) | 187 | 44.3 (34.67–54.34) |
BMI, kg/m2 | ||||||
<25 | 3,317 | 9.8 (8.56–11.24) | 1,942 | 9.5 (7.90–11.42) | 1,375 | 10.2 (8.33–12.52) |
≥25 < 30 | 6,108 | 14.2 (13.10–15.35) | 3,375 | 13.5 (11.98–15.12) | 2,733 | 15.0 (13.39–16.67) |
≥30 | 6,897 | 22.4 (21.08–23.69) | 4,470 | 23.1 (21.39–24.89) | 2,427 | 21.4 (19.49–23.41) |
Missing | 63 | 31.3 (20.36–44.88) | 33 | 31.9 (18.27–49.49) | 30 | 33.6 (21.79–47.83) |
Diabetes is based on FPG, 2-h OGTT, A1C, or scanned medications. Values except sample size are weighted for study design and nonresponse, and age is standardized to Census 2010 U.S. population.